SCHEMBL5262986

SCHEMBL5262986

Cc1ccc(C(=O)Nc2cccc(C(C)C)c2)cc1

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 5/20 0.60
RAB9A P51151 5/20 0.60
GAA P10253 1/20 0.58
HTT P42858 1/20 0.58
FADS1 O60427 1/20 0.58
CSF1R P07333 1/20 0.58
KCNK3 O14649 5/20 0.54
KCNK9 Q9NPC2 4/20 0.54
MEN1 O00255 3/20 0.54
KMT2A Q03164 3/20 0.54
KCNH2 Q12809 1/20 0.54
RXFP1 Q9HBX9 1/20 0.54
POLB P06746 1/20 0.54
SMN1; SMN2 Q16637 2/20 0.54
TP53 P04637 1/20 0.54
NFKB1 P19838 1/20 0.54
NFKB2 Q00653 1/20 0.54
RELA Q04206 1/20 0.54
ALDH1A1 P00352 1/20 0.53
CYP1A2 P05177 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23844180 0.91 RAB9A (0.62) NPC1RAB9AHTTFADS1KCNK3
SCHEMBL21133272 0.88 FADS1 (0.58) NPC1RAB9AHTTFADS1KCNK3
SCHEMBL8458801 0.88 RXRA (0.59) NPC1RAB9AHTTFADS1KCNK3
SCHEMBL8283426 0.88 KCNK9 (0.69) NPC1RAB9AGAAHTTFADS1
SCHEMBL9978845 0.87 FADS1 (0.64) NPC1RAB9AHTTFADS1KCNK3
SCHEMBL22629693 0.87 KCNK3 (0.74) NPC1RAB9AGAACSF1RKCNK3
SCHEMBL22628664 0.87 MEN1 (0.71) NPC1RAB9AFADS1KCNK3KCNK9
SCHEMBL24211467 0.87 KCNK3 (0.62) NPC1RAB9AFADS1KCNK3KCNK9
SCHEMBL23844177 0.86 FADS1 (0.62) NPC1RAB9AHTTFADS1KCNK3
SCHEMBL12228168 0.85 RAB9A (0.71) NPC1RAB9AKCNK3KCNK9MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1751136-A2 NITROGENATED HETEROCYCLIC DERIVATIVES AS PROTEIN KINASE MODULATORS AND USE FOR THE TREATMENT OF ANGIOGENESIS AND CANCER AMGEN INC. (US) 2007-02-14 EP claimed
WO-2005113494-A2 NITROGENATED HETEROCYCLIC DERIVATIVES AS PROTEIN KINASE MODULATORS AND USE FOR THE TREATMENT OF ANGIOGENESIS AND CANCER AMGEN INC. (US) 2005-12-01 WO claimed
US-20200369901-A1 DISPERSION, INK JET RECORDING METHOD, RECORDED MATERIAL, AND COMPOUND FUJIFILM CORPORATION (JP) 2020-11-26 US disclosed